XRCC1 and head and neck cancer: To test this hypothesis, we performed a hospital based case-control study using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay to genotype two polymorphisms of DNA repair gene XRCC1 Arg194Trp and Arg399Gln in relation to head and neck cancer susceptibility.